vs

Side-by-side financial comparison of Astrana Health, Inc. (ASTH) and Red Rock Resorts, Inc. (RRR). Click either name above to swap in a different company.

Astrana Health, Inc. is the larger business by last-quarter revenue ($950.5M vs $507.3M, roughly 1.9× Red Rock Resorts, Inc.). Red Rock Resorts, Inc. runs the higher net margin — 16.3% vs 0.7%, a 15.6% gap on every dollar of revenue. On growth, Astrana Health, Inc. posted the faster year-over-year revenue change (42.9% vs 1.9%). Over the past eight quarters, Astrana Health, Inc.'s revenue compounded faster (53.3% CAGR vs 2.1%).

Astrana Health, Inc. is a U.S.-based value-based healthcare services provider that primarily serves Medicare-eligible senior populations across the United States. It offers in-home primary care, chronic disease management, and care coordination services, aiming to improve patient health outcomes and reduce unnecessary medical costs.

Wynn Resorts, Limited is an American publicly traded corporation based in Paradise, Nevada, that is a developer and operator of high-end hotels and casinos. It was founded in 2002 by former Mirage Resorts Chairman and CEO Steve Wynn and is now run by CEO Craig Billings. As of 2020, the company has developed six properties.

ASTH vs RRR — Head-to-Head

Bigger by revenue
ASTH
ASTH
1.9× larger
ASTH
$950.5M
$507.3M
RRR
Growing faster (revenue YoY)
ASTH
ASTH
+41.0% gap
ASTH
42.9%
1.9%
RRR
Higher net margin
RRR
RRR
15.6% more per $
RRR
16.3%
0.7%
ASTH
Faster 2-yr revenue CAGR
ASTH
ASTH
Annualised
ASTH
53.3%
2.1%
RRR

Income Statement — Q4 FY2025 vs Q1 FY2026

Metric
ASTH
ASTH
RRR
RRR
Revenue
$950.5M
$507.3M
Net Profit
$6.6M
$82.7M
Gross Margin
Operating Margin
1.9%
28.3%
Net Margin
0.7%
16.3%
Revenue YoY
42.9%
1.9%
Net Profit YoY
184.4%
-3.8%
EPS (diluted)
$0.12
$0.73

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ASTH
ASTH
RRR
RRR
Q1 26
$507.3M
Q4 25
$950.5M
$511.8M
Q3 25
$956.0M
$475.6M
Q2 25
$654.8M
$526.3M
Q1 25
$620.4M
$497.9M
Q4 24
$665.2M
$495.7M
Q3 24
$478.7M
$468.0M
Q2 24
$486.3M
$486.4M
Net Profit
ASTH
ASTH
RRR
RRR
Q1 26
$82.7M
Q4 25
$6.6M
$44.7M
Q3 25
$373.0K
$42.3M
Q2 25
$9.4M
$56.4M
Q1 25
$6.7M
$44.7M
Q4 24
$-7.8M
$46.6M
Q3 24
$16.1M
$29.0M
Q2 24
$19.2M
$35.7M
Operating Margin
ASTH
ASTH
RRR
RRR
Q1 26
28.3%
Q4 25
1.9%
28.1%
Q3 25
2.0%
27.6%
Q2 25
3.1%
31.9%
Q1 25
3.3%
31.0%
Q4 24
0.1%
28.7%
Q3 24
5.9%
27.9%
Q2 24
6.2%
28.8%
Net Margin
ASTH
ASTH
RRR
RRR
Q1 26
16.3%
Q4 25
0.7%
8.7%
Q3 25
0.0%
8.9%
Q2 25
1.4%
10.7%
Q1 25
1.1%
9.0%
Q4 24
-1.2%
9.4%
Q3 24
3.4%
6.2%
Q2 24
3.9%
7.3%
EPS (diluted)
ASTH
ASTH
RRR
RRR
Q1 26
$0.73
Q4 25
$0.12
$0.74
Q3 25
$0.01
$0.68
Q2 25
$0.19
$0.95
Q1 25
$0.14
$0.75
Q4 24
$-0.14
$0.78
Q3 24
$0.33
$0.48
Q2 24
$0.40
$0.59

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ASTH
ASTH
RRR
RRR
Cash + ST InvestmentsLiquidity on hand
$429.5M
Total DebtLower is stronger
Stockholders' EquityBook value
$779.3M
Total Assets
$2.2B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ASTH
ASTH
RRR
RRR
Q1 26
Q4 25
$429.5M
$142.5M
Q3 25
$463.4M
$129.8M
Q2 25
$342.1M
$145.2M
Q1 25
$260.9M
$150.6M
Q4 24
$290.8M
$164.4M
Q3 24
$350.3M
$117.5M
Q2 24
$327.7M
$136.4M
Total Debt
ASTH
ASTH
RRR
RRR
Q1 26
Q4 25
$3.4B
Q3 25
Q2 25
Q1 25
Q4 24
$3.4B
Q3 24
Q2 24
Stockholders' Equity
ASTH
ASTH
RRR
RRR
Q1 26
Q4 25
$779.3M
$208.3M
Q3 25
$775.5M
$219.6M
Q2 25
$765.5M
$203.4M
Q1 25
$745.4M
$247.1M
Q4 24
$712.7M
$215.1M
Q3 24
$704.6M
$175.5M
Q2 24
$678.9M
$159.0M
Total Assets
ASTH
ASTH
RRR
RRR
Q1 26
Q4 25
$2.2B
$4.2B
Q3 25
$2.2B
$4.1B
Q2 25
$1.4B
$4.0B
Q1 25
$1.3B
$4.1B
Q4 24
$1.4B
$4.0B
Q3 24
$1.3B
$4.0B
Q2 24
$1.3B
$4.0B
Debt / Equity
ASTH
ASTH
RRR
RRR
Q1 26
Q4 25
16.30×
Q3 25
Q2 25
Q1 25
Q4 24
15.84×
Q3 24
Q2 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ASTH
ASTH
RRR
RRR
Operating Cash FlowLast quarter
$-2.9M
Free Cash FlowOCF − Capex
$-6.0M
FCF MarginFCF / Revenue
-0.6%
Capex IntensityCapex / Revenue
0.3%
Cash ConversionOCF / Net Profit
-0.44×
TTM Free Cash FlowTrailing 4 quarters
$104.5M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ASTH
ASTH
RRR
RRR
Q1 26
Q4 25
$-2.9M
$156.6M
Q3 25
$10.0M
$168.3M
Q2 25
$90.9M
$158.4M
Q1 25
$16.6M
$126.2M
Q4 24
$-10.9M
$148.2M
Q3 24
$34.0M
$131.0M
Q2 24
$23.2M
$142.5M
Free Cash Flow
ASTH
ASTH
RRR
RRR
Q1 26
Q4 25
$-6.0M
$77.7M
Q3 25
$7.4M
$74.6M
Q2 25
$89.5M
$80.3M
Q1 25
$13.6M
$58.0M
Q4 24
$-13.5M
$121.4M
Q3 24
$31.7M
$50.7M
Q2 24
$20.4M
$64.0M
FCF Margin
ASTH
ASTH
RRR
RRR
Q1 26
Q4 25
-0.6%
15.2%
Q3 25
0.8%
15.7%
Q2 25
13.7%
15.3%
Q1 25
2.2%
11.6%
Q4 24
-2.0%
24.5%
Q3 24
6.6%
10.8%
Q2 24
4.2%
13.1%
Capex Intensity
ASTH
ASTH
RRR
RRR
Q1 26
Q4 25
0.3%
15.4%
Q3 25
0.3%
19.7%
Q2 25
0.2%
14.9%
Q1 25
0.5%
13.7%
Q4 24
0.4%
5.4%
Q3 24
0.5%
17.2%
Q2 24
0.6%
16.2%
Cash Conversion
ASTH
ASTH
RRR
RRR
Q1 26
Q4 25
-0.44×
3.51×
Q3 25
26.69×
3.98×
Q2 25
9.65×
2.81×
Q1 25
2.48×
2.82×
Q4 24
3.18×
Q3 24
2.11×
4.53×
Q2 24
1.21×
4.00×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

ASTH
ASTH

Medicare$542.4M57%
Commercial$99.1M10%
Care Delivery$92.1M10%
Care Enablement$78.9M8%
Other Third Parties$58.0M6%
Health Care Patient Service$39.8M4%
Health Care Other$25.5M3%
Other$12.1M1%
Management Service$10.3M1%

RRR
RRR

Casino$340.5M67%
Food and beverage$90.3M18%
Room$45.5M9%
Other$26.2M5%
Native American management and development fees$4.7M1%

Related Comparisons